Nasal swab firm ships 15 mln kits after Apple lends hand

Reuters2021-02-22

By Stephen Nellis

Feb 22 (Reuters) - Apple Inc said on Monday nasal swab maker COPAN Diagnostics has shipped 15 million COVID-19 sample collection kits to hospitals in California, Texas and other U.S. states, bolstered by manufacturing help from the tech giant.

Apple awarded $10 million

to the Murrieta, California-based company in May last year and sent engineers to help revamp the production process at a time when shortages of testing supplies had slowed efforts to track the spread of the novel coronavirus.

The iPhone maker had initially aimed to help COPAN go from making several thousand kits per week to 1 million kits a week, with the firms also looking to create at least 50 new jobs in Southern California.

Apple did not say on Monday whether the 1-million-kit-per-week goal had been hit, but said COPAN had increased its production by nearly 4,000%, opened a new facility and hired 250 employees.

"The driver behind that was that everybody wanted to make a difference within a time frame where we could make a difference," Normal Sharples, COPAN's chief executive, said in a statement.

(Reporting by Stephen Nellis in San Francisco; Editing by Devika Syamnath)

((Stephen.Nellis@thomsonreuters.com; (415) 344-4934;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
2